RecruitingACTRN12616001269426

Out-of-pocket costs in cancer patients in Sydney, Australia: A pilot study


Sponsor

Concord Repatriation General Hospital

Enrollment

50 participants

Start Date

Jul 14, 2016

Study Type

Observational

Conditions

Summary

This study aims to collect out-of-pocket costs of treatment and management of cancer in patients in three centres in Sydney, Australia. Who is it for? You may be eligible to join this study if you are aged 18 years or above, have a diagnosis of any cancer (early or advanced), are receiving at least one cancer-directed therapy which is expected to continue for at least 3 months, and are under the care of a Medical Oncologist at a centre participating in the study. Study details All participants will complete a questionnaire collecting basic details about their age, income status, sociodemographic details and those of their cancer and it's treatment. They will also complete up to 3 cost diaries which will collect information regarding out-of-pocket costs of their treatment, investigations, appointments, and travel. Participants will grade on a Likert scale how easy to how difficult it was to complete the diaries. Finally, participants will also be required to complete two questionnaires at the end of the three month study period, to evaluate financial distress/toxicity. The information that is collected will help to inform healthcare professionals, patients and government bodies of the costs of cancer treatment and the impact of these costs.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This pilot study is collecting information about the out-of-pocket costs that cancer patients pay for their treatment, such as travel, appointments, and medications not fully covered by insurance. Researchers want to understand the financial burden of cancer treatment in Sydney and how it affects patients' wellbeing. You may be eligible if: - You are 18 years of age or older - You have a diagnosis of any type of cancer (early or advanced) - You are currently receiving cancer treatment (chemotherapy, hormone therapy, etc.) expected to last at least 3 months - You are under the care of a medical oncologist at a participating Sydney centre - You can read and complete written questionnaires You may NOT be eligible if: - Your general health and functioning are significantly limited (Karnofsky score below 50) - You cannot complete written questionnaires - Your life expectancy is less than 6 months Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

1. Recruitment of participants A consecutive sample of eligible patients will be recruited for this feasibility study. Patients potentially suitable for the study (age >18 yrs, currently receiving

1. Recruitment of participants A consecutive sample of eligible patients will be recruited for this feasibility study. Patients potentially suitable for the study (age >18 yrs, currently receiving anti-cancer therapy expected to continue for at least 3 months, able to complete a written diary) will be identified upon review of the clinic list by the coordinating investigator, or researcher, and oncologist at the start of the clinic day. 2. Consent Consent will be obtained by the coordinating investigator or researcher after the study has been introduced to the patient by the treating oncologist. 3. Initial questionnaire For consenting patients, they will be provided with a questionnaire asking them details regarding their demographics, income level, insurance status etc. The treating oncologist will be required to complete details pertaining to the patients’ cancer diagnosis and treatment details. 4. Oncologists’ Estimates The treating oncologist will be requested to complete a form asking to provide a figure of estimated monthly out-of-pocket expense for their patient for cancer-related therapy. 5. Cost Diary Out-of-pocket costs The costs diary will be provided on a monthly basis and will ask patients to provide details of: 1. Cancer-related prescription medication (include out-of-pocket cost, reason, money back from insurance/PBS and prescriber) 2. Cancer-related non-prescription medication including complementary and alternative medicines, over-the-counter medication 3. All medication (cancer-related or not, prescribed or over-the-counter) out-of-pocket costs 4. Cancer-related imaging, pathology and doctor’s consultation fees (Medicare Benefits Schedule item number, fee, copayment, refund from health insurance) 5. Travel costs 6. Cancer-related miscellaneous costs including complementary and alternative therapy e.g. massage, aromatherapy, acupuncture etc. Include out-of-pocket cost, reason, money back from insurance/PBS and prescriber/referrer. Participants will be asked to complete the monthly cost diary for an overall duration of 3 months. 6. Financial distress/toxicity Two surveys will be required to be completed by particpants : a financial toxicity COST-PROM survey and a cost-saving strategy survey. The surveys for assessing financial distress will be provided at the end of the three months of the study period.


Locations(3)

Concord Repatriation Hospital - Concord

NSW, Australia

The Chris O’Brien Lifehouse - Camperdown

NSW, Australia

Bankstown-Lidcombe Hospital - Bankstown

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12616001269426


Related Trials